AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution
2024 · Nature · 52 citations
https://doi.org/10.1038/s41586-024-08031-6
A
Alycia Gardner
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
2.3K
Citations
12
h-index
14
i10-index
Alycia Gardner is an academic researcher. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Ferroptosis and cancer prognosis & Epigenetics and DNA Methylation. The author has an h-index of 12, co-authored 41 publications.
ORCID: 0000-0003-2185-5174Papers by this author
worksFucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy
2023 · Nature Cancer · 48 citations
https://doi.org/10.1038/s43018-022-00506-7
Figure S1 from DAB2IP is a bifunctional tumor suppressor that regulates wildtype RAS and inflammatory cascades in KRAS mutant colon cancer
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27027476
Supplementary Figure S5 from Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS<i>-</i>Mutant Colorectal Cancers
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27938792
Supplementary Figure S1 from Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS<i>-</i>Mutant Colorectal Cancers
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27938804
Supplementary Figure S7 from Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS<i>-</i>Mutant Colorectal Cancers
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27938786
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat